ForGrowth III PA B.V. - 23 Oct 2025 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
ForGrowth III PA B.V.	7.4%	1.83M	1.83M	/s/ V. van Houten and /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors of its Director
Forbion Growth Opportunities Fund III Cooperatief U.A.	7.4%	1.83M	1.83M	/s/ V. van Houten and /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors of its Director
Forbion Growth III Management B.V.	7.4%	1.83M	1.83M	/s/ V. van Houten and /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors